Integrated Diagnostics (UK) Performance
| IDHC Stock | 0.40 0.02 5.26% |
Integrated Diagnostics has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of -0.0603, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Integrated Diagnostics are expected to decrease at a much lower rate. During the bear market, Integrated Diagnostics is likely to outperform the market. Integrated Diagnostics right now retains a risk of 3.58%. Please check out Integrated Diagnostics maximum drawdown, skewness, daily balance of power, as well as the relationship between the potential upside and kurtosis , to decide if Integrated Diagnostics will be following its current trending patterns.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Integrated Diagnostics Holdings are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Integrated Diagnostics may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Last Split Factor 4:1 | Ex Dividend Date 2022-06-16 | Last Split Date 2020-12-24 |
1 | Integrated Diagnostics Holdings Sees Strong Revenue Growth in 2024 - TipRanks | 11/13/2024 |
2 | Integrated Diagnostics Holdings PLC Q3 2024 Earnings Call Highlights Strong Revenue ... By GuruFocus - Investing.com Canada | 11/21/2024 |
| Begin Period Cash Flow | 648.5 M |
Integrated |
Integrated Diagnostics Relative Risk vs. Return Landscape
If you would invest 37.00 in Integrated Diagnostics Holdings on August 30, 2024 and sell it today you would earn a total of 3.00 from holding Integrated Diagnostics Holdings or generate 8.11% return on investment over 90 days. Integrated Diagnostics Holdings is generating 0.1845% of daily returns and assumes 3.5771% volatility on return distribution over the 90 days horizon. Simply put, 31% of stocks are less volatile than Integrated, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Integrated Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integrated Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Integrated Diagnostics Holdings, and traders can use it to determine the average amount a Integrated Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0516
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IDHC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.58 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.18 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Integrated Diagnostics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integrated Diagnostics by adding it to a well-diversified portfolio.
Integrated Diagnostics Fundamentals Growth
Integrated Stock prices reflect investors' perceptions of the future prospects and financial health of Integrated Diagnostics, and Integrated Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Integrated Stock performance.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0969 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 232.12 M | ||||
| Shares Outstanding | 581.33 M | ||||
| Price To Book | 4.15 X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 4.12 B | ||||
| Gross Profit | 2.8 B | ||||
| EBITDA | 1.28 B | ||||
| Net Income | 737.36 M | ||||
| Total Debt | 1.18 B | ||||
| Book Value Per Share | 4.64 X | ||||
| Cash Flow From Operations | 543.66 M | ||||
| Earnings Per Share | 0.03 X | ||||
| Total Asset | 5.77 B | ||||
| Retained Earnings | 1.33 B | ||||
About Integrated Diagnostics Performance
Assessing Integrated Diagnostics' fundamental ratios provides investors with valuable insights into Integrated Diagnostics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Integrated Diagnostics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Integrated Diagnostics is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Integrated Diagnostics performance evaluation
Checking the ongoing alerts about Integrated Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Integrated Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Integrated Diagnostics has some characteristics of a very speculative penny stock | |
| Integrated Diagnostics had very high historical volatility over the last 90 days | |
| Integrated Diagnostics is unlikely to experience financial distress in the next 2 years | |
| About 34.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Integrated Diagnostics Holdings PLC Q3 2024 Earnings Call Highlights Strong Revenue ... By GuruFocus - Investing.com Canada |
- Analyzing Integrated Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Integrated Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Integrated Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Integrated Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Integrated Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Integrated Diagnostics' stock. These opinions can provide insight into Integrated Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.